Pivoting to Generative AI for Antibodies

Exploring the company's transition from sin bio to generative AI within antibodies, detailing the integration of scalable wet lab technology with AI to revolutionize antibody discovery. The chapter also discusses the challenges and importance of aligning the team's vision for successful integration.